p53 mutations in chondrosarcoma

Diagnostic Molecular Pathology

Volumn 7, Issue 1, 1998, Pages 51-56

  Terek, Richard M ^a,c   Healey, John H ^b   Garin Chesa, Pilar ^b   Mak, Solida ^a   Huvos, Andrew ^b   Albino, Anthony P ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c University Orthopedics Incorporated   (United States)

Author keywords

Bone tumors; Cartilage; Chondrosarcoma; P53; Single strand conformational polymorphism; Tumor suppressor genes

Indexed keywords

ALANINE; CYTOSINE; DNA; GUANINE; MONOCLONAL ANTIBODY; PROLINE; PROTEIN P53; RNA;

AMINO ACID SUBSTITUTION; ARTICLE; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BONE NEOPLASMS; CELL DIFFERENTIATION; CHONDROSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031802903     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199802000-00009     Document Type: Article

References (34)

1. Adams ME, Huang DQ, Yao LY, Sandell LJ. Extraction and isolation of mRNA from adult articular cartilage. Anal Biochem 1992; 202:89-95.
2. Albino AP, Vidai MJ, McNutt NS, et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994;4:35-45.
3. Chin KV, Ueda E, Pastan I, Gottesman MM. Modulation of activity of the promoter of the human MDRI gene by Ras and p53. Science 1992;255:459-62.
4. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-9.
5. Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J. p53 mutations in breast cancer. Cancer Res 1992;52:5291-8.
6. Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD. p53 expression and DNA ploidy of cartilage lesions. Hum Pathol 1995; 26:620-4.
7. Danenberg PV, Horikoshi T, Volkenandt M, et al. Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s). Nucleic Acids Res 1992;20:573-9.
8. Dicker AP, Volkenandt M, Albino AP. Mutational analysis of human NRAS genes in malignant melanomas: rapid methods for oligonucleotide hybridization and manual and automated direct chain reaction [review]. Genes Chromosomes Cancer 1990;1:257-69.
9. Dobashi Y, Sugimura H, Sato A, et al. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Diagn Mol Pathol 1993;2:257-63.
10. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New Engl J Med 1993;329:1318-27.
11. Hasegawa T, Seki K, Yang P, Hirose T, Hizawa K, Wada T, Wakabayashi J. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol 1995;26:838-45.
12. Hollstein M, Rice K, Greenblatt MS, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994;22:3551-5.
13. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
14. Hsu H-C, Peng S, Lai P, Chu J, Lee P. Mutations of p53 gene in hepatocellular carcinoma (HCC) correlate with tumor progression and patient prognosis: a study of 138 patients with unifocal HCC. Int J Oncology 1994;4:1341-7.
15. Huvos AG. Chondrosarcoma including spindle-cell (dedifferentiated) and myxoid chondrosarcoma; mesenchymal chondrosarcoma. In: Bone tumors, 2nd ed. Philadelphia: WB Saunders, 1991;355-62.
16. Kovar H, Auinger A, Jug G, et al. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene 1993;8:2683-90.
17. Malkin D, Jolly KW, Barbier N. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992;326:1309-15.
18. Murray V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res 1989;17:8889.
19. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86:2766-70.
20. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
21. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
23. Simms WW, Ordonez NG, Johnston D, Ayala AG, Czerniak B. p53 expression in dedifferentiated chondrosarcoma. Cancer 1995; 76:223-7.
24. Smale G, Sasse J. RNA isolation from cartilage using density gradient centrifugation in cesium trifluoroacetate: an RNA preparation technique effective in the presence of high proteoglycan content. Anal Biochem 1992;203:352-6.
25. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:747-9.
26. Sugimoto K, Toyoshima H, Sakai R, et al. Mutations of the p53 gene in lymphoid leukemia. Blood 1991;77:1153-6.
27. Suzuki Y, Tamura G. Mutations of the p53 gene in carcinomas of the urinary system. Acta Pathologica Japonica 1992;43:745-50.
28. Tateyama H, Eimoto T, Tada T, et al. p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study. Am J Clin Pathol 1995;104: 375-81.
29. Terek RM, Schwartz G, Devaney K, et al. Chemotherapy and p-glycoprotein expression in chondrosarcoma. J Orthop Res, in press.
30. Thor AD, Yandell DW. Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism. J Natl Cancer Inst 1993;85:176-7.
31. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene is bone and soft tissue sarcomas. Cancer Res 1992; 52:6194-9.
32. Ueda Y, Dockhorn-Dworniczak B, Blasius S, Mellin W, Wuisman P, Bocker W, Roessner A. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 1993;119:172-8.
33. Van Den Broek MH, Renault B, Fodde R, Verspaget H, Griffioen G, Khan PM. Sites and types of p53 mutations in an unselected series of colorectal cancers in the Netherlands. Anticancer Res 1993;13:587-92.
34. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y, Yamamuro T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 1993;68: 1134-9.